NNS 2026

All Sessions by Todd Kilbaugh

5:15 pm - 7:00 pm

POB.130 - Clinical Trial of Inhaled Nitric Oxide for Treatment of Microvascular Dysfunction in Acute Traumatic Brain Injury: Preliminary Report

5:15 pm - 7:00 pm

POB.158 - Fc-Engineered Monoclonal Antibodies Targeting neoGFAP™ as a Disease-Modifying Immunotherapy for Traumatic Brain Injury

4:30 pm - 6:30 pm

POA.08 - Mechanistically Anchored Age-Adjusted Trajectories of neoGFAP™ as a Blood Biomarker for Pediatric Traumatic Brain Injury Monitoring: Pilot Studies with NfL